The Supreme Court on Monday temporarily restored broad access to the abortion pill mifepristone, blocking a lower court ruling that had threatened to upend one of the main ways abortion is provided across the nation.
Key Takeaways
The Supreme Court temporarily restored access to the abortion pill mifepristone through telehealth, mail, and pharmacies. The ruling blocks a lower court's restrictions that threatened to upend medication abortions nationwide.
- Supreme Court restores broad access to mifepristone
- Justice Samuel Alito issues temporary order allowing pharmacy and mail access
- Federal appeals court had imposed new restrictions last week
- Majority of U.S. abortions are obtained through medications, blunting impact of state bans
In an order signed by Justice Samuel Alito, women seeking abortions can obtain the pill at pharmacies or through the mail without an in-person visit to a doctor. These rules had been in effect for several years until a federal appeals court imposed new restrictions last week.
The majority of abortions in the U.S. are obtained through medications, usually a combination of mifepristone and misoprostol. Their availability has blunted the impact of abortion bans that most Republican-led states have started enforcing since the Supreme Court's 2022 ruling that overturned Roe v. Wade.
Louisiana sued to restrict access to mifepristone, asserting that its availability undermined the ban there. Some Democratic-led states have laws seeking to give legal protection to those who prescribe the drugs via telehealth to patients in states with bans.
How this summary was created
This summary synthesizes reporting from 3 independent publishers using AI. All sources are cited and linked below. NewsBalance is a news aggregator and media literacy tool, not a news publisher. AI-generated content may contain errors or inaccuracies — always verify important information with the original sources.